Overview

68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC)

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study was used to study the diagnostic value of 68Ga-FAPI, a novel fibroblast activating inhibitor, in metastatic adenoid cystic carcinoma（ACC）
Phase:
N/A
Details
Lead Sponsor:
Peking Union Medical College Hospital